Publication of Groundbreaking Study on Ultra-Sensitive Molecular Residual Disease Detection in EMBO Molecular Medicine
August 20, 2024
The study showed 90% sensitivity and 100% specificity in colorectal cancer patient blood samples collected within six weeks after surgery.